Both in Pharmaceuticals
Skye Bioscience vs Alaunos Therapeutics
Over the past year SKYE returned −85.9% and TCRT returned +11.2%; their daily moves had a correlation of -0.00.
SKYE −85.9% TCRT +11.2%Growth of $1, one year, split-adjusted
| Metric | SKYE | TCRT |
|---|---|---|
| Price | $1.63 | $3.08 |
| Market cap | $7.2M | $7.8M |
| Today | +0.62% | +3.70% |
| 1 month | −4.7% | +142.5% |
| 6 months | −77.4% | +12.8% |
| Year to date | −72.8% | −4.6% |
| 1 year | −84.7% | 0.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 2,608.2× |
| Net cash | $9.9M | $124.0K |
| Dividend yield | — | — |
| Volatility (60d) | 616.8% | 263.8% |
| Short % of float | 0.7% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).